CMPX

Compass Therapeutics, Inc. CMPX

$2.05 -0.05 (-2.38%)

Pullback · -1.04σ

+ Compare Open in Sniper

Mkt cap $0.4B

P/E —

Day $2.01 – $2.12

52wk $1.61 – $6.88

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Compass Therapeutics, Inc. is a healthcare company listed in the US.

CMPX last traded at $2.05, down 2.4% on the day; that's in the lower part of its 52-week range ($1.61–$6.88). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Verdict

Unknown

Accounting quality Adequate

✓ More cash than debt
✓ Current ratio 15.02 (antifragile)
✓ Debt/equity 0.12 (antifragile)

⚠ Negative retained earnings

Key statistics

All statistics →

CMPX is a $388 million company, the stock is trading near the bottom of its 52-week range.

Mkt cap $0.4B

P/E ttm —

Fwd P/E —

Beta —

Day range $2.01 – $2.12

52w range $1.61 – $6.88

Avg vol —

RSI(2) 1.1

ROE —

Net mgn —

FCF mgn —

Debt/Eq 0.05

Div yld —

Sector Healthcare

Industry Biotechnology

Next earn —

52-week range · today's price

$1.61$6.88